As Asia’s private equity braved yet another year of headwinds, the dynamics in the industry shifted considerably. From the emergence of new strategies to capital flow seeking new alpha, the diversity of Asia and an underpenetrated private capital market make it an exciting region to invest in. Go to Source
Author: Deal Street Asia Online News
Bain Capital offers to buy Australia’s Insignia Financial for $1.7bThe 178-year-old wealth manager has been valued at $1.7b.
Australia’s Insignia Financial said on Friday it has received a non-binding takeover all-cash proposal from private equity Bain Capital, valuing the 178-year-old wealth manager at A$2.67 billion ($1.70 billion). Under the offer, Insignia shareholders will receive A$4.00 per share, which represents a 17.6% premium to the stock’s closing price of A$3.40 on Thursday. The stock shot… Continue reading Bain Capital offers to buy Australia’s Insignia Financial for $1.7bThe 178-year-old wealth manager has been valued at $1.7b.
UK regulatory approval for Shein’s IPO delayed by NGO opposition: reportAn advocacy group for China’s Uyghur population challenged the listing.
Britain’s financial regulator is taking longer than usual to approve fast-fashion retailer Shein‘s IPO because it is checking its supply chain oversight and assessing legal risks after an advocacy group for China’s Uyghur population challenged the listing, according to two sources close to the matter. Britain’s Independent Anti-Slavery Commissioner, a monitoring body of the interior ministry,… Continue reading UK regulatory approval for Shein’s IPO delayed by NGO opposition: reportAn advocacy group for China’s Uyghur population challenged the listing.
Vishal Mega Mart’s $943m India IPO fully subscribed on Day 2Still, retail investors were not as hungry for the IPO.
Indian budget retailer Vishal Mega Mart’s $943 million IPO was fully subscribed on the second day of bids on Thursday, though a flood of recent offerings dulled retail investors’ appetite for a company analysts say is immune to its bigger rivals’ problems. The issue got bids for 1.17 billion shares at the end of the second day… Continue reading Vishal Mega Mart’s $943m India IPO fully subscribed on Day 2Still, retail investors were not as hungry for the IPO.
APAC may beat global markets in PE returns recovery: PreqinGrowth and fund-of-funds strategies are expected to boost returns.
Asia Pacific (APAC) private equity is likely to emerge as an outlier over the next five years as returns globally are forecast to cool down, according to Preqin’s Private Equity 2025 report. The private market data firm projected that returns will ease across most private equity strategies and regions, except for APAC, during the six-year… Continue reading APAC may beat global markets in PE returns recovery: PreqinGrowth and fund-of-funds strategies are expected to boost returns.
Australia fines Kraken crypto exchange $5.1m for issuing credit facility to customersASIC said the bourse failed to determine the right customers for …
Australia’s corporate watchdog said on Thursday that the country’s federal court ordered crypto exchange Kraken’s local operator to pay an A$8 million ($5.1 million) fine for unlawfully issuing a credit facility to more than 1,100 customers. The Australian Securities and Investments Commission (ASIC) initiated civil proceedings last year against Bit Trade, which operates the Kraken… Continue reading Australia fines Kraken crypto exchange $5.1m for issuing credit facility to customersASIC said the bourse failed to determine the right customers for …
Bosch’s China-focused Boyuan Capital targets $207m for second RMB fundBoyuan Capital has held the first close of its second fund at 500 million yuan (…
Go to Source
Bain Capital leads $120m Series C for Angitia BiopharmaThe latest round comes 10 months after its $40m Series B extension led by China’s YueKai Health…
Angitia Biopharmaceuticals, a clinical-stage biotech firm with operations in the US and China, has secured $120 million in a Series C round of financing led by Bain Capital Life Sciences. The Woodland Hills, California-based company also raised capital from new investor Janus Henderson and existing investors including US healthcare investment firm OrbiMed, as well as… Continue reading Bain Capital leads $120m Series C for Angitia BiopharmaThe latest round comes 10 months after its $40m Series B extension led by China’s YueKai Health…
Bain, KKR, JIP advance to next round of bidding for Seven & i’s non-core opsYork Holdings has 31 companies under its umbrella.
Go to Source
Temasek-backed Vertex Ventures leans on India in 2024, but will 2025 be different?In 2024, India accounted for about two-thirds of its new investments…
Temasek-backed Vertex Ventures’s portfolio in 2024 was dominated by India, which accounted for two-thirds of its investments driven by a surge in high-quality, capital-efficient startups, a top executive told DealStreetAsia, adding that the firm’s future deal pipeline is also skewed towards the world’s fifth-largest economy. Go to Source